An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program
Chronic lymphatic leukemia (CLL) is the most frequent type of leukemia in western countries and when association with del(11q) is correlated with a worse prognosis. We reported the clinical case of an 80-year-old patient with CLL related to del(11q) and a BMI of 16.4 kg/m<sup>2</sup>, wh...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | International Journal of Environmental Research and Public Health |
Subjects: | |
Online Access: | https://www.mdpi.com/1660-4601/17/6/1929 |
id |
doaj-daa59018a6c94b69883fc1b81d9b187b |
---|---|
record_format |
Article |
spelling |
doaj-daa59018a6c94b69883fc1b81d9b187b2020-11-25T02:52:31ZengMDPI AGInternational Journal of Environmental Research and Public Health1660-46012020-03-01176192910.3390/ijerph17061929ijerph17061929An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity ProgramAntonello Sica0Caterina Sagnelli1Alfonso Papa2Massimo Ciccozzi3Evangelista Sagnelli4Armando Calogero5Erika Martinelli6Beniamino Casale7Department of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, ItalyDepartment of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, ItalyPain Department, AORN Dei Colli V. Monaldi, 80131 Naples, ItalyMedical Statistics and Molecular Epidemiology, Campus Bio-Medico University, 00100 Rome, ItalyDepartment of Mental Health and Public Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, ItalyDepartment of Advanced Biomedical Sciences, University of Naples Federico II, 80131 Naples, ItalyDepartment of Precision Medicine, University of Campania Luigi Vanvitelli, 80131 Naples, ItalyDepartment of Pneumology and Tisiology, AORN Dei Colli - V. Monaldi, 80131 Naples, ItalyChronic lymphatic leukemia (CLL) is the most frequent type of leukemia in western countries and when association with del(11q) is correlated with a worse prognosis. We reported the clinical case of an 80-year-old patient with CLL related to del(11q) and a BMI of 16.4 kg/m<sup>2</sup>, who presented a voluminous mass in abdominal cavity (23 × 14 × 4 cm) which occupied the whole of the mesentery and the retroperitoneal space, treated with ibrutinib, adequate nutrition, and a program of physical activity. He showed a great improvement under ibrutinib therapy and took to artificial nourishment and adequate muscle rehabilitation until he recovered his autonomy. In August 2018, a 5-days-a-week training program was started: Physical activity for at least 20 min consisting of a fast walk in the open air three times a week and a moderate physical activity in the remaining two days of at least 20 consecutive minutes (cycling at a regular pace, carrying light weights). The exercise program included also aerobic, upper and lower limb resistance training, chore stability and stretches. The physical condition further improved and remained excellent throughout the follow-up period. In December 2018, his clinical condition was quite normal; a CT showed a great decrease of all lymphoadenomegaly, and FISH test did not show del(11q). He continued to cultivate his land, while still being treated with ibrutinib. The combination of the right therapy, adequate nutrition, and muscle rehabilitation is the best solution to improve the clinical condition of old cachectic CLL del(11q) patient.https://www.mdpi.com/1660-4601/17/6/1929physical activityelder ageclldel(11q)ibrutinib |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Antonello Sica Caterina Sagnelli Alfonso Papa Massimo Ciccozzi Evangelista Sagnelli Armando Calogero Erika Martinelli Beniamino Casale |
spellingShingle |
Antonello Sica Caterina Sagnelli Alfonso Papa Massimo Ciccozzi Evangelista Sagnelli Armando Calogero Erika Martinelli Beniamino Casale An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program International Journal of Environmental Research and Public Health physical activity elder age cll del(11q) ibrutinib |
author_facet |
Antonello Sica Caterina Sagnelli Alfonso Papa Massimo Ciccozzi Evangelista Sagnelli Armando Calogero Erika Martinelli Beniamino Casale |
author_sort |
Antonello Sica |
title |
An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program |
title_short |
An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program |
title_full |
An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program |
title_fullStr |
An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program |
title_full_unstemmed |
An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity Program |
title_sort |
anecdotal case report of chronic lymphatic leukemia with del(11q) treated with ibrutinib: artificial nourishment and physical activity program |
publisher |
MDPI AG |
series |
International Journal of Environmental Research and Public Health |
issn |
1660-4601 |
publishDate |
2020-03-01 |
description |
Chronic lymphatic leukemia (CLL) is the most frequent type of leukemia in western countries and when association with del(11q) is correlated with a worse prognosis. We reported the clinical case of an 80-year-old patient with CLL related to del(11q) and a BMI of 16.4 kg/m<sup>2</sup>, who presented a voluminous mass in abdominal cavity (23 × 14 × 4 cm) which occupied the whole of the mesentery and the retroperitoneal space, treated with ibrutinib, adequate nutrition, and a program of physical activity. He showed a great improvement under ibrutinib therapy and took to artificial nourishment and adequate muscle rehabilitation until he recovered his autonomy. In August 2018, a 5-days-a-week training program was started: Physical activity for at least 20 min consisting of a fast walk in the open air three times a week and a moderate physical activity in the remaining two days of at least 20 consecutive minutes (cycling at a regular pace, carrying light weights). The exercise program included also aerobic, upper and lower limb resistance training, chore stability and stretches. The physical condition further improved and remained excellent throughout the follow-up period. In December 2018, his clinical condition was quite normal; a CT showed a great decrease of all lymphoadenomegaly, and FISH test did not show del(11q). He continued to cultivate his land, while still being treated with ibrutinib. The combination of the right therapy, adequate nutrition, and muscle rehabilitation is the best solution to improve the clinical condition of old cachectic CLL del(11q) patient. |
topic |
physical activity elder age cll del(11q) ibrutinib |
url |
https://www.mdpi.com/1660-4601/17/6/1929 |
work_keys_str_mv |
AT antonellosica ananecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT caterinasagnelli ananecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT alfonsopapa ananecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT massimociccozzi ananecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT evangelistasagnelli ananecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT armandocalogero ananecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT erikamartinelli ananecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT beniaminocasale ananecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT antonellosica anecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT caterinasagnelli anecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT alfonsopapa anecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT massimociccozzi anecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT evangelistasagnelli anecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT armandocalogero anecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT erikamartinelli anecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram AT beniaminocasale anecdotalcasereportofchroniclymphaticleukemiawithdel11qtreatedwithibrutinibartificialnourishmentandphysicalactivityprogram |
_version_ |
1724729438683267072 |